Status: current, Defined. Date: 31-Jan 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4306751000168115 | Fasenra (benralizumab 30 mg / 1 mL) injection, 1 mL pen device (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4306761000168118 | Fasenra 30 mg/mL injection, 1 mL pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fasenra 30 mg/mL injection, 1 mL pen device | Is a | Fasenra | true | Inferred relationship | Some | ||
| Fasenra 30 mg/mL injection, 1 mL pen device | Is a | benralizumab 30 mg/mL injection, pen device | true | Inferred relationship | Some | ||
| Fasenra 30 mg/mL injection, 1 mL pen device | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Fasenra 30 mg/mL injection, 1 mL pen device | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Fasenra 30 mg/mL injection, 1 mL pen device | has unit of use | pen device | true | Inferred relationship | Some | 1222636226 | |
| Fasenra 30 mg/mL injection, 1 mL pen device | has Australian BoSS | benralizumab | true | Inferred relationship | Some | 1168180084 | |
| Fasenra 30 mg/mL injection, 1 mL pen device | has intended active ingredient | benralizumab | true | Inferred relationship | Some | 1168180084 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fasenra 30 mg/mL injection, 1 mL pen device | has TPUU | True | Fasenra 30 mg/mL injection, 1 mL pen device | Inferred relationship | Some | 13981402 |
| Fasenra 30 mg/mL injection, 1 mL pen device | has TPUU | True | Fasenra 30 mg/mL injection, 1 mL pen device | Inferred relationship | Some | 720105502 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR